<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <title>karadeniz MD Derneği</title>
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <meta content="Free HTML Templates" name="keywords">
    <meta content="Free HTML Templates" name="description">

    <!-- Favicon -->
    <link href="img/kms_logo.webp" rel="icon">

    <!-- Google Web Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Nunito:wght@400;600;700;800&family=Rubik:wght@400;500;600;700&display=swap" rel="stylesheet">

    <!-- Icon Font Stylesheet -->
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.10.0/css/all.min.css" rel="stylesheet">
    <link href="https://cdn.jsdelivr.net/npm/bootstrap-icons@1.4.1/font/bootstrap-icons.css" rel="stylesheet">

    <!-- Libraries Stylesheet -->
    <link href="lib/owlcarousel/assets/owl.carousel.min.css" rel="stylesheet">
    <link href="lib/animate/animate.min.css" rel="stylesheet">

    <!-- Customized Bootstrap Stylesheet -->
    <link href="css/bootstrap.min.css" rel="stylesheet">

    <!-- Template Stylesheet -->
    <link href="css/style.css" rel="stylesheet">

    <style>
        .navbar-nav {
            margin: auto;
        }
        
        .navbar-nav .nav-link {
            padding-left: 20px;
            padding-right: 20px;
        }
    </style>
    <style>
        .logo img {
            max-height: 120px;
            max-width: 200px;
        }
        .bg-header {
        background: linear-gradient(rgba(9, 30, 62, .7), rgba(9, 30, 62, .7)), url(img/40269.jpg) center center no-repeat;
        background-size: cover;
        }

    </style>
</head>

<body>
    <!-- Spinner Start -->
    <div id="spinner" class="show bg-white position-fixed translate-middle w-100 vh-100 top-50 start-50 d-flex align-items-center justify-content-center">
        <div class="spinner"></div>
    </div>
    <!-- Spinner End -->


    <!-- Topbar Start -->
    <div class="container-fluid bg-dark px-5 d-none d-lg-block">
        <div class="row gx-0">
            <div class="col-lg-8 text-center text-lg-start mb-2 mb-lg-0">
                <div class="d-inline-flex align-items-center" style="height: 45px;">
                    <small class="me-3 text-light"><i class="fa fa-map-marker-alt me-2"></i>Atakum/SAMSUN </small>
                    <small class="me-3 text-light"><i class="fa fa-phone-alt me-2"></i>0 362 319 19 19 / Dahili :
                        3077</small>
                    <small class="text-light"><i class="fa fa-envelope-open me-2"></i>
                        karadenizms@karadenizms.com</small>
                </div>
            </div>
            <div class="col-lg-4 text-center text-lg-end">
                <div class="d-inline-flex align-items-center" style="height: 45px;">
                    <span class="text-light"><strong>Karadeniz Ms</strong></span>
                </div>
            </div>
        </div>
    </div>
    <!-- Topbar End -->


    <!-- Navbar & Carousel Start -->
    <div class="container-fluid position-relative p-0">
        <nav class="navbar navbar-expand-lg navbar-dark px-5 py-3 py-lg-0">
            <div class="logo">
                <a href="index.html">
                    <img src="img/kms_logo.webp" alt="Your Logo">
                </a>
            </div>

            <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse">
                <span class="fa fa-bars"></span>
            </button>
            <div class="collapse navbar-collapse" id="navbarCollapse">
                <div class="navbar-nav ms-auto py-0">
                    <a href="index.html" class="nav-item nav-link">Ana Sayfa</a>
                    <a href="msbulusma.html" class="nav-item nav-link">MS Buluşması</a>
                    <a href="klinikcalismalar.html" class="nav-item nav-link active">Klinik Çalışmalar</a>
                    <div class="nav-item dropdown">
                        <a href="msnedir.html" class="nav-link dropdown-toggle" data-bs-toggle="dropdown">MS Nedir?</a>
                        <div class="dropdown-menu m-0">
                            <a href="msnedir.html" class="dropdown-item">MS Nedir?</a>
                            <a href="hastalikNeden.html" class="dropdown-item">Hastalığın nedenleri nedir?</a>
                            <a href="hastalikBelirti.html" class="dropdown-item">Hastalığın belirtileri nelerdir?</a>
                            <a href="hastalikYas.html" class="dropdown-item">MS en çok hangi yaşta ortaya çıkar?</a>
                            <a href="hastalikUlke.html" class="dropdown-item">MS en çok hangi ülkelerde sık görülür?</a>
                        </div>
                    </div>
                    <div class="nav-item dropdown">
                        <a href="dernegimiz.html" class="nav-link dropdown-toggle" data-bs-toggle="dropdown">Derneğimiz</a>
                        <div class="dropdown-menu m-0">
                            <a href="dernegimiz.html" class="dropdown-item">Derneğimiz</a>
                            <a href="lib\tuzuk.pdf" target="_blank" class="dropdown-item">Tüzüğümüz</a>
                            <a href="uyeler.html" class="dropdown-item">Üyelerimiz</a>
                        </div>
                    </div>
                    <div class="nav-item dropdown">
                        <a href="etkinlikler.html" class="nav-link dropdown-toggle" data-bs-toggle="dropdown">Etkinlikler</a>
                        <div class="dropdown-menu m-0">
                            <a href="msEtkinlikler/msHastaOkulu.html" class="dropdown-item">MS Hasta Okulu</a>
                            <a href="msEtkinlikler/msHastaZiyareti.html" class="dropdown-item">Hasta Ziyaretleri</a>
                            <a href="msEtkinlikler/ms3HastaOkulu.html" class="dropdown-item">3. Hasta Okulu</a>
                            <a href="msEtkinlikler/msSempozyum.html" class="dropdown-item">MS Sempozyum 24 ARALIK</a>
                            <a href="msEtkinlikler/ms4HastaKamp.html" class="dropdown-item">4. MS Hasta Kampı</a>
                            <a href="msEtkinlikler/msKoroFormu.html" class="dropdown-item">MS Koro Formu</a>
                            <a href="msEtkinlikler/msFotograf.html" class="dropdown-item">Fotoğraf Yarışması</a>
                            <a href="msEtkinlikler/ms6Kamp.html" class="dropdown-item">6. Multipl Skleroz Hasta Kampı</a>
                            <a href="msEtkinlikler/ms6Kamp.html" class="dropdown-item">7. Multipl Skleroz Hasta Kampı</a>
                            <a href="msEtkinlikler/ms9Basvuru.html" class="dropdown-item">9. Kamp Başvuru Formu</a>
                        </div>
                    </div>
                    <a href="mssozlugu.html" class="nav-item nav-link">MS Sözlüğü</a>
                    <a href="ziyaretcidefteri.html" class="nav-item nav-link">Ziyaretçi Defteri</a>
                    <a href="iletisim.html" class="nav-item nav-link">İletişim</a>
                </div>
            </div>
        </nav>
        <div class="container-fluid bg-primary py-5 bg-header" style="margin-bottom: 90px;">
            <div class="row py-5">
                <div class="col-12 pt-lg-5 mt-lg-5 text-center">
                    <h1 class="display-4 text-white animated zoomIn">KLİNİK ÇALIŞMALARI</h1>
                </div>
            </div>
        </div>
            
        </div-->
    </div>
    <!-- Navbar & Carousel End -->


    <!-- Full Screen Search Start -->
    <div class="modal fade" id="searchModal" tabindex="-1">
        <div class="modal-dialog modal-fullscreen">
            <div class="modal-content" style="background: rgba(9, 30, 62, .7);">
                <div class="modal-header border-0">
                    <button type="button" class="btn bg-white btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
                </div>
                <div class="modal-body d-flex align-items-center justify-content-center">
                    <div class="input-group" style="max-width: 600px;">
                        <input type="text" class="form-control bg-transparent border-primary p-3" placeholder="Type search keyword">
                        <button class="btn btn-primary px-4"><i class="bi bi-search"></i></button>
                    </div>
                </div>
            </div>
        </div>
    </div>


    <!-- Service Start -->
    <div class="container-fluid py-5 wow fadeInUp" data-wow-delay="0.1s">
        <div class="container py-5">
            <div class="section-title text-center position-relative pb-3 mb-5 mx-auto" style="max-width: 600px;">
                <h3 class="fw-bold text-primary text-uppercase">KLİNİK ÇALIŞMALAR VE DETAYLARI</h3>
                <h5 class="mb-0">19 Mayıs Üniversitesi Nöroloji Anabilim dalı kliniğinde Multipl Skleroz (MS) ile ilgili ulusal ve uluslararası
                    bir çok klinik çalışma yürütülmektedir.</h5>
            </div>
            <div class="row g-5">
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis (TOWER)</h4>
                        <p class="m-0"> Nüks ile seyreden multipl skleroz hastalarında, teriflunomidin etkililik ve güvenliliğini araştırmak 
                            için çok-merkezli, çift-kör, paralel-gruplu, plasebo-kontrollü bir çalışma, TOWER ” başlıklı “EFC10531”</p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT00751881?term=EFC10531&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis</h4>
                        <p class="m-0"> 
                            Relaps Yapan Multipl Sklerozlu Hastalarda Interferon Beta-1a (Rebif) ile Karşılaştırmalı Olarak Ocrelizumab’ın Etkililik 
                            ve Güvenliliğinin Değerlendirildiği Randomize, Çift Kör, Çift Plasebolu, Paralel Grup Çalışması WA21093
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01412333?term=WA21093" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3"> Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)</h4>
                        <p class="m-0">
                             Sekonder progresif multipl sklerozu olan hastalarda Siponimod’un (BAF312) etkililik ve güvenliliğinin değerlendirildiği çok merkezli, 
                            randomize, çift kör, paralel gruplu, plasebo kontrollü, değişken tedavi süreli bir çalışma” isimli CBAF312A2304 kodlu çalışma
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01665144?term=CBAF312A2304&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <!--3-->
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">Extension Study of MT-1303</h4>
                        <p class="m-0"> 
                            MT-1303-E04 protokol numaralı, “Tekrarlayan ve Düzelen (relapsing-remitting) Multipl Skleroz hastalarında 24 hafta süresince  
                            MT-1303’ün üç farklı oral doz uygulamasının güvenlilik ve etkililiğini değerlendiren çok merkezli, randomize, çift kör, 
                            paralel grup, plasebo kontrollü, Faz II doz belirleme çalışması
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01890655?term=MT-1303-E04&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">Extension Study of MT-1303-2</h4>
                        <p class="m-0"> 
                            MT-1303-E05 protokol numaralı, “MT -1303-E04 çalışmasını tamamlamış, Tekrarlayan ve Düzelen 
                            (relapsing-remitting) Multipl Skleroz hastalarında, MT-1303’ün uzun süreli güvenlilik ve 
                            etkililiğini değerlendiren çok merkezli Faz II çalışma
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01890655?term=MT-1303-E05&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients</h4>
                        <p class="m-0">                 
                            Nükseden nöromiyelitis optika (NMO) görülen hastalarda ekulizumabın güvenliliğinin ve etkililiğinin değerlendirildiği ECU-NMO-301'in faz 3, 
                            açık etiketli çalışması
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT02003144?term=ECU-NMO-301&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <!--6-->
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">                     
                        <h4 class="mb-3">An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients-2</h4>
                        <p class="m-0"> 
                            Nükseden nöromiyelitis optika (NMO) görülen hastalarda ekulizumabın güvenliliğinin ve etkililiğinin değerlendirildiği 
                            ECU-NMO-301'in faz 3, açık etiketli uzatma çalışması
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT02200770?term=CD-IA-MEDI-551-1155&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h5 class="mb-3">A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders</h5>
                        <p class="m-0">                
                            Açık etiketli Dönem A Double-maskeli, plasebo-kontrollü çalışma No'lu Protokol'ün CD-IA-MEDİ-551-1155 Nöromiyelitis Optica ve Nöromiyelitis Optica Spektrum Bozukluğu, Erişkin Bireylerde etkililik ve MEDİ-551 Güvenliğini değerlendirimi
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT02200770?term=CD-IA-MEDI-551-1155&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>       
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis</h4>
                        <p class="m-0"> 
                            Relapsta seyreden multipl skleroz formlarının görüldüğü hastalarda günde birkez oral olarak uygulanan 0,5 mg fingolimodun( FTY720) uzun süreli güvenlilik ve tolerabilitesini değerlendiren tek kollu, açık etiketlli, çok merkezli bir çalışması
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01201356?term=CFTY720D2399&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
<!--9-->
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">FTY720 in Patients With Primary Progressive Multiple Sclerosis (INFORMS)</h4>
                        <p class="m-0"> 
                            Primer ilerleyici multipl skleroz bulunan hastalarda günde birkez oral olarak uygulanan 0,5mg FTY720 nin etkililik ve güvenliğinin plasebo ile 
                            karşılaştırıldığı çift-kör , randomize, çok merkezli, plasebo-kontrollü, paralel-gruplu bir çalışma
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT00731692?term=CFTY720D2306&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>                
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720</h4>
                        <p class="m-0"> 
                            Relapsing remitting multipl skleroz hastalarında Fingolimod tedavisinin değerlendirildiği 12 aylık,açık etiketli,çok merkezli pilot 
                            çalışma-FINE çalışması başlıklı,CFTY720DTR01 protokol numaralı faz IV klinik araştırma
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01578330?term=CFTY720DTR01&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>      
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)</h4>
                        <p class="m-0"> 
                            Çok merkezli,randomize,çift kör,paralel gruplu,placebo kontrollü değişken tedavili seconder progresif multiple sclerosis hastalarında siponimod  etkililiğini ve güvenliğini değerlendirmek
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01665144?term=CBAF312A2304&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
<!--12-->
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis</h4>
                        <p class="m-0"> 
                            Multipl skleroz hastalarında AIN457 (secukinumab )nin etkinliğini ve güvenilirliğini değerlendirmek için adaptif doz çaplı, çok merkezli, randomize, çift kör, paralel gruplu, plasebo kontrollü Faz 2 çalışması
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT01874340?term=CAIN457B2203&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">Drugs for multiple sclerosis Summaries of key information and evidence for efficacy and safety (FACT)</h4>
                        <p class="m-0"> 
                            Oral MS ilacı Türkiye deneyimi CFTY720DTR02 protokol   kodlu çalışması
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://www.birmingham.ac.uk/Documents/college-mds/haps/projects/WMCSU/WorkProgramme/EvidenceReviews/MS-drugs/DrugFactsBoxforFingolimod.pdf" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">ECU-MG-302: An Extension Trial of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis</h4>
                        <p class="m-0"> 
                            Refrakter Jeneralize Miyastenia Gravis’i (gMG) olan gönüllülerde Ekulizumabın güvenliliği ve etkililiğini değerlendiren randomize, Çift Kör, Plasebo Kontrollü, çok merkezli  çalışma
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT02301624?term=ECU-MG-301&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
                <!--15-->
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">ECU-MG-302: An Extension Trial of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis </h4>
                        <p class="m-0"> 
                            Refrakter jeneralize Myastenia Gravis (gMG) görülen gönüllülerde ekulizumabın güvenliliği ve etkililiğini değerlendiren ECU-MG-301 için faz III, açık etiketli uzatma çalışması
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT02301624?term=ECU-MG-302&rank=1" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>

                
                
                <div class="col-lg-4 col-md-6 wow zoomIn" data-wow-delay="0.3s">
                    <div class="service-item bg-light rounded d-flex flex-column align-items-center justify-content-center text-center">
                        
                        <h4 class="mb-3">Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS (FOCUS)</h4>
                        <p class="m-0"> 
                            Tekrarlayan ve düzelen (relapsing-remitting) 10-17 yaş arası pediatrik Multipl Skleroz hastalarında BG0012’ nin MR lezyonları ve farmakokinetik üzerine etkisinin değerlendirildiği,açık etiketli,çok merkezli,çok dozlu çalışma
                        </p>
                        <a class="btn btn-lg btn-primary rounded" href="https://clinicaltrials.gov/ct2/show/NCT02410200?term=109MS202&rank=2" target="_blank">
                            <i class="bi bi-arrow-right"></i>
                        </a>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <!-- Service End -->


    <!-- Vendor Start -->
    <div class="container-fluid py-5 wow fadeInUp" data-wow-delay="0.1s">
        <div class="container py-5 mb-5">
            <div class="bg-white">
                <div class="owl-carousel vendor-carousel">
                    <img src="img/adapha_logo.webp" alt="">
                    <img src="img/kms_logo.webp" alt="">
                    <img src="img/ondokuz_mayis_universitesi_logo.webp" alt="">
                </div>
            </div>
        </div>
    </div>
    <!-- Vendor End -->

    <!-- Footer Start -->
    <div class="container-fluid bg-dark text-light mt-5 wow fadeInUp" data-wow-delay="0.1s">
        <div class="container">
            <div class="row gx-5">
                <div class="col-lg-12 col-md-6">
                    <div class="row gx-5">
                        <div class="col-lg-3 col-md-6 pt-0 pt-lg-5 mb-5">

                            <div class="d-flex mb-2">
                                <i class="bi bi-geo-alt text-primary me-2"></i>
                                <p class="mb-0">Atakum/SAMSUN</p>
                            </div>
                            <div class="d-flex mb-2">
                                <i class="bi bi-envelope-open text-primary me-2"></i>
                                <p class="mb-0">karadenizms@karadenizms.com</p>
                            </div>
                            <div class="d-flex mb-2">
                                <i class="bi bi-telephone text-primary me-2"></i>
                                <p class="mb-0">0 362 319 19 19 / Dahili : 3077</p>
                            </div>
                        </div>
                        <div class="col-lg-3 col-md-6 pt-0 pt-lg-5 mb-5">
                            <div class="section-title section-title-sm position-relative pb-3 mb-4">
                            </div>
                            <div class="link-animated d-flex flex-column justify-content-start">
                                <a class="text-light mb-2" href="index.html"><i class="bi bi-arrow-right text-primary me-2"></i>Ana Sayfa</a>
                                <a class="text-light mb-2" href="msnedir.html"><i class="bi bi-arrow-right text-primary me-2"></i>MS Nedir?</a>
                                <a class="text-light mb-2" href="dernegimiz.html"><i class="bi bi-arrow-right text-primary me-2"></i>Derneğimiz</a>
                            </div>
                        </div>
                        <div class="col-lg-3 col-md-6 pt-0 pt-lg-5 mb-5">
                            <div class="section-title section-title-sm position-relative pb-3 mb-4">
                            </div>
                            <div class="link-animated d-flex flex-column justify-content-start">
                                <a class="text-light mb-2" href="klinikcalismalar.html"><i class="bi bi-arrow-right text-primary me-2"></i>Klinik Çalışmalar</a>
                                <a class="text-light mb-2" href="msbulusma.html"><i class="bi bi-arrow-right text-primary me-2"></i>MS Buluşma</a>
                                <a class="text-light mb-2" href="lib/tuzuk.pdf"><i class="bi bi-arrow-right text-primary me-2"></i>Tüzüğümüz</a>
                            </div>
                        </div>
                        <div class="col-lg-3 col-md-6 pt-0 pt-lg-5 mb-5">
                            <div class="section-title section-title-sm position-relative pb-3 mb-4">
                            </div>
                            <div class="link-animated d-flex flex-column justify-content-start">
                                <a class="text-light mb-2" href="ziyaretcidefteri.html"><i class="bi bi-arrow-right text-primary me-2"></i>Ziyaretçi Defteri</a>
                                <a class="text-light mb-2" href="mssozlugu.html"><i class="bi bi-arrow-right text-primary me-2"></i>MS Sözlüğü</a>
                                <a class="text-light mb-2" href="iletisim.html"><i class="bi bi-arrow-right text-primary me-2"></i>İletişim</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>


    <div class="container-fluid text-white" style="background: #061429;">
        <div class="container text-center">
            <div class="row justify-content-center">
                <div class="col-lg-8 col-md-6">
                    <div class="d-flex align-items-center justify-content-center" style="height: 75px;">
                        <p class="mb-0">&copy; <a class="text-white border-bottom" href="index.html">Karadeniz MS Derneği</a>. All Rights Reserved. Design by

                            <!--/*** This template is free as long as you keep the footer author’s credit link/attribution link/backlink. If you'd like to use the template without the footer author’s credit link/attribution link/backlink, you can purchase the Credit Removal License from "https://htmlcodex.com/credit-removal". Thank you for your support. ***/-->
                            <a class="text-white border-bottom" href="https://htmlcodex.com">HTML Codex</a></p>
                            
                    </div>
                </div>
            </div>
        </div>
    </div>
    <!-- Footer End -->


    <!-- Back to Top -->
    <a href="#" class="btn btn-lg btn-primary btn-lg-square rounded back-to-top"><i class="bi bi-arrow-up"></i></a>


    <!-- JavaScript Libraries -->
    <script src="https://code.jquery.com/jquery-3.4.1.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0/dist/js/bootstrap.bundle.min.js"></script>
    <script src="lib/wow/wow.min.js"></script>
    <script src="lib/easing/easing.min.js"></script>
    <script src="lib/waypoints/waypoints.min.js"></script>
    <script src="lib/counterup/counterup.min.js"></script>
    <script src="lib/owlcarousel/owl.carousel.min.js"></script>

    <!-- Template Javascript -->
    <script src="js/main.js"></script>
</body>

</html>